Difference between revisions of "Part:BBa K4165007"
Line 6: | Line 6: | ||
− | + | ||
===Usage and Biology=== | ===Usage and Biology=== | ||
+ | |||
+ | WWW peptide is designed to inhibit the fibrilization of tau which is one of the main drivers of Alzheimer’s disease and other dementia diseases. PHF* (VQIINK) is the site that derives tau aggregation. WWW can bind to PHF* in a means that can disrupt the interface between each PHF* and consequently reduce the aggregates. Accordingly, this peptide would be suitable to act as the targeting domain in our systems. | ||
+ | |||
<!-- --> | <!-- --> |
Revision as of 19:17, 4 October 2022
WWW (Tau binding peptide)
Synthetic peptide used to bind to the aggregations of misfolded tau protein (BBa_) and toxic Amyloid beta plaques (BBa_).
Usage and Biology
WWW peptide is designed to inhibit the fibrilization of tau which is one of the main drivers of Alzheimer’s disease and other dementia diseases. PHF* (VQIINK) is the site that derives tau aggregation. WWW can bind to PHF* in a means that can disrupt the interface between each PHF* and consequently reduce the aggregates. Accordingly, this peptide would be suitable to act as the targeting domain in our systems.
Sequence and Features
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]